Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants

January 5, 2012 updated by: Han-Suk Kim, Seoul National University Hospital

Application of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants and Assessment of Its Benefits Compared to Synchronized Intermittent Mandatory Ventilation (SIMV) With Pressure Support (PS)

The purpose of this study is to test the hypothesis that neurally adjusted ventilatory assist (NAVA) will allow to lower the ventilator pressure at equivalent fractions of inspiratory oxygen (FiO2) and partial pressure of CO2 of capillary blood in preterm infants in comparison with currently used standard ventilation (synchronized intermittent mandatory ventilation with pressure-support ventilation, SIMV+PSV).

Study Overview

Detailed Description

The investigators will apply crossover comparison in preterm infants who received a ventilatory support. In patient whose frequency of mandatory support is under 25, the two ventilatory modes (SIMV+PSV and NAVA) are delivered by the same ventilator (Servo-I; Maquet Critical Care AB, Solna, Sweden) and will set to maintain similar blood gas analysis results.

Determination of the type of ventilatory mode used is performed using a cluster randomization. The randomized order of ventilatory mode will be used during total 9 hours; one mode for 4 hours and another mode for 5 hours. To rule out carry-over effects, a 1-hour interval for washout was guaranteed between modes. Recordings will be obtained over a total 8 hours.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 110-733
        • Seoul National University Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 2 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • preterm infants mechanically ventilated
  • ventilatory set frequency is under 25
  • with informed consent of their parents

Exclusion Criteria:

  • major congenital anomalies
  • patients without self respiratory effort
  • use of sedative or anesthetic drugs
  • grade III or IV intraventricular hemorrhage
  • phrenic nerve palsy or insufficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ventilator assist
Neurally adjusted ventilatory assist (NAVA) utilizes the electrical activity of the diaphragm (EAdi) to trigger and cycle-off breaths, and therefore presents a means of bypassing the ventilator circuit, and the inherent delays with pneumatic triggering. This is a processed signal, which is not artificially influenced by changes in muscle length, chest wall configuration, and/or lung volume. It represents the summation of muscle motor unit recruitment and/or firing rate, and correlates with phrenic nerve activity. In this mode, the amount of support pressure is coupled with the magnitude of the EAdi. The proportion of support pressure to EAdi (NAVA level) is adjustable.
Other Names:
  • Servo-i (Maquet Critical Care AB, Solna, Sweden)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak Inspiratory Pressure
Time Frame: four hours
peak inspiratory pressure measured by a ventilator for 4 hours with each ventilator mode
four hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Airway Pressure
Time Frame: four hours
mean airway pressure measured by a ventilator for 4 hours with each ventilator mode
four hours
Minute Ventilation
Time Frame: four hours
Minute ventilation measured by a ventilator for 4 hours with each ventilator mode
four hours
Expiratory Tidal Volume
Time Frame: four hours
Expiratory tidal volume measured by a ventilator for 4 hours with each ventilator mode
four hours
Dynamic Compliance
Time Frame: four hours
Dynamic Compliance measured by a ventilator for 4 hours with each ventilator mode
four hours
Work of Breathing
Time Frame: four hours
Work of breathing of patients measured by a ventilator for 4 hours with each ventilator mode
four hours
Peak EAdi
Time Frame: four hours
Peak electrical activity of the diaphragm
four hours
Fraction of Oxygen
Time Frame: four hours
Fraction of oxygen measured by a ventilator for 4 hours with each ventilator mode
four hours
Capillary Blood pH
Time Frame: four hours
Capillary blood pH checked immediately after the 4-hour respiratory support with each ventilator mode
four hours
Capillary Blood pCO2
Time Frame: four hours
Capillary blood pCO2 checked immediately after the 4-hour respiratory support with each ventilator mode
four hours
Capillary Blood pO2
Time Frame: four hours
Capillary blood pO2 checked immediately after the 4-hour respiratory support with each ventilator mode
four hours
Capillary Blood HCO3
Time Frame: four hours
Capillary blood HCO3 checked immediately after the 4-hour respiratory support with each ventilator mode
four hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Han Suk Kim, Ph.D, Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

August 1, 2011

Study Registration Dates

First Submitted

July 1, 2011

First Submitted That Met QC Criteria

July 6, 2011

First Posted (Estimate)

July 8, 2011

Study Record Updates

Last Update Posted (Estimate)

January 9, 2012

Last Update Submitted That Met QC Criteria

January 5, 2012

Last Verified

January 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant, Preterm

Clinical Trials on neurally adjusted ventilatory assist (NAVA) ventilator mode

3
Subscribe